Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A European Multicenter, Randomized, Parallel-group Study to Evaluate the Safety and Efficacy/Performance of DAV132 in Hospitalized Patients at High Risk for Clostridium Difficile Infection and Who Receive Fluoroquinolones for the Treatment of Acute Infections

NCT03710694 is registered in ClinicalTrials.gov with Da Volterra as lead sponsor.

NCT NCT03710694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03710694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A European Multicenter, Randomized, Parallel-group Study to Evaluate the Safety and Efficacy/Performance of DAV132 in Hospitalized Patients at High Risk for Clostridium Difficile Infection and Who Receive Fluoroquinolones for the Treatment of Acute Infections
Lead sponsor
Da Volterra
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2018
Completion date
August 9, 2019
Enrollment
260 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection